PE20071028A1 - SUSTAINED RELEASE DOSAGE FORMS OF BENZISOXAZOLE DERIVATIVES - Google Patents
SUSTAINED RELEASE DOSAGE FORMS OF BENZISOXAZOLE DERIVATIVESInfo
- Publication number
- PE20071028A1 PE20071028A1 PE2006001268A PE2006001268A PE20071028A1 PE 20071028 A1 PE20071028 A1 PE 20071028A1 PE 2006001268 A PE2006001268 A PE 2006001268A PE 2006001268 A PE2006001268 A PE 2006001268A PE 20071028 A1 PE20071028 A1 PE 20071028A1
- Authority
- PE
- Peru
- Prior art keywords
- benzisoxazole
- dosage forms
- sustained release
- release dosage
- benzisoxazole derivatives
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- 150000008316 benzisoxazoles Chemical class 0.000 title abstract 2
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 abstract 2
- 230000003204 osmotic effect Effects 0.000 abstract 2
- PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 239000007902 hard capsule Substances 0.000 abstract 1
- 229960001057 paliperidone Drugs 0.000 abstract 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001534 risperidone Drugs 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 239000007901 soft capsule Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UNA FORMA DE DOSIFICACION DE LIBERACION SOSTENIDA ORAL QUE COMPRENDE UN DERIVADO DE BENZISOXAZOL TAL COMO PALIPERIDONA Y RISPERIDONA, DONDE DICHA FORMA DE DOSIFICACION ES DE LIBERACION SOSTENIDA OSMOTICA Y EL COMPONENTE BENZISOXAZOL SE ENCUENTRA ENTRE EL 10% Y 90% EN PESO DE LA COMPOSICION. LAS FORMAS DE DOSIFICACION OSMOTICA PUEDEN PRESENTARSE BAJO LA FORMA DE CAPSULA BLANDA O CAPSULA DURA. LA DOSIFICACION DESCRITA ES UTIL EN EL TRATAMIENTO DE LA ESQUIZOFRENIA Y/O DE LA MANIA BIPOLARREFERRED TO AN ORAL SUSTAINED RELEASE DOSAGE FORM THAT INCLUDES A BENZISOXAZOLE DERIVATIVE SUCH AS PALIPERIDONE AND RISPERIDONE, WHERE SAID DOSAGE FORM IS SUSTAINED OSMOTIC RELEASE AND THE BENZISOXAZOLE COMPONENT IN 10% IS CONTAINED IN THE 10% BENZISOXAZOLE COMPONENT IN 90% . OSMOTIC DOSAGE FORMS MAY BE PRESENTED IN THE FORM OF SOFT CAPSULE OR HARD CAPSULE. THE DESCRIBED DOSAGE IS USEFUL IN THE TREATMENT OF SCHIZOPHRENIA AND / OR BIPOLAR MANIA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72862005P | 2005-10-19 | 2005-10-19 | |
| US11/262,113 US20060189635A1 (en) | 2005-02-04 | 2005-10-27 | Enhanced efficacy benzisoxazole derivative dosage forms and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071028A1 true PE20071028A1 (en) | 2007-11-30 |
Family
ID=38734884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001268A PE20071028A1 (en) | 2005-10-19 | 2006-10-19 | SUSTAINED RELEASE DOSAGE FORMS OF BENZISOXAZOLE DERIVATIVES |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR057161A1 (en) |
| GT (1) | GT200600467A (en) |
| PE (1) | PE20071028A1 (en) |
| TW (1) | TW200731970A (en) |
| UY (1) | UY29877A1 (en) |
-
2006
- 2006-10-18 TW TW095138307A patent/TW200731970A/en unknown
- 2006-10-19 AR ARP060104568 patent/AR057161A1/en not_active Application Discontinuation
- 2006-10-19 PE PE2006001268A patent/PE20071028A1/en not_active Application Discontinuation
- 2006-10-19 UY UY29877A patent/UY29877A1/en unknown
- 2006-10-19 GT GT200600467A patent/GT200600467A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200600467A (en) | 2007-09-21 |
| TW200731970A (en) | 2007-09-01 |
| AR057161A1 (en) | 2007-11-21 |
| UY29877A1 (en) | 2006-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR073123A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTANTIALLY AMORFO TAXANE TO BE USED IN THE TREATMENT OF NEOPLASIC DISEASE | |
| ECSP12011935A (en) | TRIAZOLOPIRIDINS | |
| AR072261A1 (en) | PIPERAZIN-PIRAZOLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME AS ANTICANCERIGEN AGENTS. | |
| DOP2016000250A (en) | AN AMORPHY FORM AND A GENZ 112638 HEMITARTRATE CRYSTALLINE AS A GLUCOSILCERAMIDE SINTASA INHIBITOR | |
| PE20131464A1 (en) | QUINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS PI3 KINASE INHIBITORS | |
| MX2020008616A (en) | SUBLINGUAL FENTANYL SPRAY. | |
| PE20170666A1 (en) | 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES | |
| CR9694A (en) | HIV REVERSE TRANSCRIPT INHIBITORS | |
| PE20140960A1 (en) | FORMULATIONS INVOLVING A DPP4 INHIBITOR | |
| AR047928A1 (en) | TETRAHYDROPIRIDOINDOL DERIVATIVES | |
| CL2013001136A1 (en) | A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent. | |
| ECSP088763A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF DEPRESSION | |
| DOP2013000244A (en) | TRIAZOLOPIRIDINS | |
| UY33452A (en) | REPLACED TRIAZOLOPIRIDINS | |
| GT200600200A (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR STROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE | |
| AR054347A1 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| UY31125A1 (en) | STABILIZED AMORPHES OF IMATINIB MESILATE | |
| UY35419A (en) | PIRROLO KINASA CDK9 INHIBITORS (2,3- B) PIRIDINE | |
| ECSP15033787A (en) | NEW RAPID DISSOLVING GRANULAR FORMULATION THAT HAS IMPROVED SOLUBILITY | |
| ECSP088761A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS | |
| ECSP10010464A (en) | USE OF RANOLAZINE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
| PE20130147A1 (en) | PHARMACEUTICAL COMBINATION OF THEOBROMINE AND A NON-OPIOID ANTITUSSIVE AGENT | |
| CL2008002060A1 (en) | Compounds derived from sulfonamide, inhibitors of beta amyloid production; Preparation method; pharmaceutical composition; pharmaceutical kit; and use in the treatment of diseases such as Alzheimer's, amyloid angiopathy, down syndrome, among others. | |
| PE20071028A1 (en) | SUSTAINED RELEASE DOSAGE FORMS OF BENZISOXAZOLE DERIVATIVES | |
| UY29134A1 (en) | SULFONAMIDS REPLACED BY BENCIMIDAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURE AND APPLICATIONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |